Publication: NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells
Issued Date
2012-08-15
Resource Type
ISSN
15387445
00085472
00085472
Other identifier(s)
2-s2.0-84865145768
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cancer Research. Vol.72, No.16 (2012), 4085-4096
Suggested Citation
Kai Lee Yap, Stephanie I. Fraley, Michelle M. Thiaville, Natini Jinawath, Kentaro Nakayama, Jianlong Wang, Tian Li Wang, Denis Wirtz, Ie Ming Shih NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells. Cancer Research. Vol.72, No.16 (2012), 4085-4096. doi:10.1158/0008-5472.CAN-12-0302 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/13638
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells
Abstract
NAC1 is a transcriptional corepressor protein that is essential to sustain cancer cell proliferation and migration. However, the underlying molecular mechanisms of NAC1 function in cancer cells remain unknown. In this study, we show that NAC1 functions as an actin monomer-binding protein. The conserved BTB protein interaction domain in NAC1 is the minimal region for actin binding. Disrupting NAC1 complex function by dominant-negative or siRNA strategies reduced cell retraction and abscission during late-stage cytokinesis, causing multinucleation in cancer cells. In Nac1-deficient murine fibroblasts, restoring NAC1 expression was sufficient to partially avert multinucleation. We found that siRNA-mediated silencing of the actin-binding protein profilin-1 in cancer cells caused a similar multinucleation phenotype and that NAC1 modulated the binding of actin to profillin-1. Taken together, our results indicate that the NAC1/actin/profilin-1 complex is crucial for cancer cell cytokinesis, with a variety of important biologic and clinical implications. ©2012 AACR.